Literature DB >> 17415859

Paul Ehrlich (1854-1915): founder of chemotherapy and pioneer of haematology, immunology and oncology.

G Androutsos1.   

Abstract

The Jewish-German histologist, microbiologist, bio- chemist, immunologist and pharmacologist Paul Ehrlich, by his research founded chemotherapy and pioneered im- munology, haematology and oncology. For his contribu- tion in immunology he was awarded the Nobel Prize of Medicine and Physiology in 1908.

Year:  2004        PMID: 17415859

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  1 in total

1.  Targeted therapy and hematological malignancy.

Authors:  James O Armitage
Journal:  Target Oncol       Date:  2009-02-14       Impact factor: 4.493

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.